USP Pharmaceutical Analytical Impurities

(3-(4-(methylamino)-1-oxoisoindolin-2-yl)piperidine-2,6-dione)

(25 mg)

(3-O-De(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)-6-O-methylerythromycin; 3-O-decladinosyl-6-O-methylerythromycin A)

((7R,8R,9S,13S,14S,17S)-13-methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)sulfonyl)nonyl)7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol)

(2-hydroxy-2,2-di(thiophen-2-yl)acetic acid)

(3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoic acid)

(Isopropyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate)

(ethyl 3-(2-((((4-(N-((heptan-2-yloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate)

((2S)-3-Phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoic acid)

(N-[(1S)-2-Amino-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide)

(4-O-(Carboxymethyl)-1-deoxy-1,4-dihydro-4-hydroxy-1-oxo-rifamycin gamma-lactones)

((R)-4-(2-((6-((2,6-dichlorobenzyl)oxy)hexyl)amino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol, 2,2,2-triphenylacetate)

((R)-4-(2-((6-(2-((2,4-dichlorobenzyl)oxy)ethoxy)hexyl)amino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol, triphenylacetate)

((R)-4-(2-((6-(2-((2,5-dichlorobenzyl)oxy)ethoxy)hexyl)amino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol, 2,2,2-triphenylacetate)

((S)-4-(2-((6-(2-((2,6-dichlorobenzyl)oxy)ethoxy)hexyl)amino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol 2,2,2-triphenylacetate)

((alphaR)-alpha-[[[6-[2-[(2,6-Dichlorophenyl)methoxy]ethoxy]hexyl]amino]methyl]-2,2-dimethyl-4H-1,3-benzodioxin-6-methanol, triphenylacetate)

((S)-4-[1-Hydroxy-2-(methylamino)ethyl]pyrocatechol; (S)-4-(1-Hydroxy-2-(methylamino)ethyl)benzene-1,2-diol)

(3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide)

(4,4'-((1R,1'R)-((oxybis(hexane-6,1-diyl))bis(azanediyl))bis(1-hydroxyethane-2,1-diyl))bis(2-(hydroxymethyl)phenol), 2,2,2-triphenylacetate))

(8-nitroso-7,8,9,10-tetrahydro-6H-6,10-methanoazepino[4.5-g]quinoxaline)

(N,N-dipropylnitrous amide)

(Methyl 2-(1-nitrosopiperidin-2-yl)-2-phenylacetate)

(1-Nitrosopiperidine)